Values as of: 2024-09-22
COMMON STOCK | Specialty Chemicals |
Last Closing
USD 5037Change
0.00 (0.00)%Market Cap
USD 46.63BVolume
64.00Analyst Target
N/AVerdict
Verdict
Givaudan SA manufactures, supplies, and sells fragrance, beauty, taste, and wellbeing products to the consumer goods industry. The company operates through divisions, Fragrance & Beauty, and Taste & Wellbeing. The Fragrance & Beauty division offers fine fragrances; consumer products, such as personal, home, fabric, and oral care; fragrance ingredients; and active beauty products. The Taste & Wellbeing division provides beverages, such as fizzy drinks, bottled waters, ready-to-drink juices, alcoholic beverages, and others; dairy and cheese products, including dairy drinks, yoghurt, ice cream, chilled desserts, cream cheese, and spreads; snacks; givaudan flavour ingredients; savory, and supplements and nutraceutical products; and biscuits, crackers, and cereals, as well as confectionery products, such as chewing gums, chocolates, and sweets. It operates in Switzerland, Europe, Africa, the Middle East, North America, Latin America, and the Asia Pacific. Givaudan SA was founded in 1796 and is headquartered in Vernier, Switzerland.
Company Website : https://www.givaudan.com
Currency: USD
Country : USA
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| AIQUY | Air Liquide SA ADR |
N/A |
USD 109.56B |
| AIQUF | L'Air Liquide S.A |
N/A |
USD 109.56B |
| SKFOF | Sika AG |
N/A |
USD 51.88B |
| SXYAY | Sika AG ADR |
N/A |
USD 50.88B |
| GVDNY | Givaudan SA ADR |
N/A |
USD 49.03B |
| DSMFF | DSM-Firmenich AG |
N/A |
USD 35.70B |
| NVZMF | Novozymes A/S B |
N/A |
USD 31.31B |
| EMSHF | EMS-CHEMIE HOLDING AG |
N/A |
USD 19.02B |
| SYIEF | Symrise AG |
N/A |
USD 18.73B |
| NPPHY | Nippon Paint Holdings Co. Ltd. |
N/A |
USD 15.13B |
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|---|
| S2USAH:SW | 2.95 % | 0.00 % |
N/A |
N/A | |
| S2EUAH:SW | 2.83 % | 0.00 % |
N/A |
N/A | |
| S2EUBH:SW | 2.62 % | 0.00 % |
N/A |
N/A | |
| S2USBH:SW | 2.62 % | 0.00 % |
N/A |
N/A | |
| HEWL | 2.52 % | 0.03 % |
N/A |
N/A | |
| EUDV | 0.00 % | 0.55 % |
N/A |
N/A | |
| EWL | iShares MSCI Switzerland .. | 0.00 % | 0.47 % |
N/A |
N/A |
| FLSW | Franklin FTSE Switzerland.. | 0.00 % | 0.09 % |
N/A |
USD 0.06B |
| UC93:LSE | UBS MSCI Switzerland 20/3.. | 0.00 % | 0.00 % |
N/A |
USD 8.51M |
| UC94:LSE | UBS(Lux)Fund Solutions .. | 0.00 % | 0.00 % |
N/A |
USD 0.06B |
| Market Performance vs. Industry/Classification (Specialty Chemicals) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | 24.37% | 84% | B | 76% | C+ | ||
| Dividend Return | 1.95% | 45% | F | 33% | F | ||
| Total Return | 26.32% | 84% | B | 76% | C+ | ||
| Trailing 12 Months | |||||||
| Capital Gain | 61.81% | 88% | B+ | 87% | B+ | ||
| Dividend Return | 2.53% | 54% | F | 36% | F | ||
| Total Return | 64.35% | 87% | B+ | 87% | B+ | ||
| Trailing 5 Years | |||||||
| Capital Gain | 80.54% | 90% | A- | 84% | B | ||
| Dividend Return | 10.24% | 41% | F | 35% | F | ||
| Total Return | 90.78% | 89% | A- | 84% | B | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 9.64% | 54% | F | 54% | F | ||
| Dividend Return | 11.28% | 53% | F | 52% | F | ||
| Total Return | 1.64% | 34% | F | 35% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 28.05% | 55% | F | 75% | C | ||
| Risk Adjusted Return | 40.19% | 77% | C+ | 77% | C+ | ||
| Market Capitalization | 46.63B | 94% | A | 98% | N/A | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The company had positive total cash flow in the most recent four quarters.
The company had positive total free cash flow in the most recent four quarters.
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The stock is trading high compared to its peers median on a price to book value basis.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The company has under performed its peers on annual average total returns in the past 5 years.
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
